Servicio
Reumatoloxía
Publicacións (100) Publicacións nas que participase algún/ha investigador/a
2020
-
A Comparative Study of Doppler Ultrasound against Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 313-318
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
Scientific Reports, Vol. 10, Núm. 1
-
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients
Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916
-
All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes
Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192
-
Amentadione from the Alga Cystoseira usneoides as a Novel Osteoarthritis Protective Agent in an Ex Vivo Co-Culture OA Model
Marine drugs, Vol. 18, Núm. 12
-
Analyses of the Genetic Polymorphisms rs3740199 and rs1871054 of the ADAM12 Gene and the Alleles at the rs2073508 Loci of the TGFB1 Gene and Their Contribution to Susceptibility to Primary Knee Osteoarthritis
Genetic Testing and Molecular Biomarkers, Vol. 24, Núm. 6, pp. 375-380
-
Angiopoietin-2 promotes inflammatory activation in monocytes of systemic sclerosis patients
International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-10
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 5, pp. 69-75
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Association between non-adherence behaviors, patients’ experience with healthcare and beliefs in medications: a survey of patients with different chronic conditions
Current Medical Research and Opinion, Vol. 36, Núm. 2, pp. 293-300
-
Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108
-
Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes
Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240
-
Biologic therapy in refractory non-multiple sclerosis optic neuritis isolated or associated to immune-mediated inflammatory diseases. A multicenter study
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-13
-
Blocking il-17: A promising strategy in the treatment of systemic rheumatic diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-14
-
Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition
Journal of Clinical Medicine, Vol. 9, Núm. 4
-
Cartilage Metabolism, Mitochondria, and Osteoarthritis
Journal of the American Academy of Orthopaedic Surgeons, Vol. 28, Núm. 6, pp. E242-E244
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 859-866
-
Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 6, pp. 1226-1237